Home
Patients
Giving
Cancer Talk
Research & Education
About
Careers
MyRoswell
Newsroom
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Study Number:
I 248613
Phase:
Early Phase
Principal Investigator:
Kunle Odunsi, MD, PhD, FRCOG, FACOG